Hsp47 fibrosis. Dec 8, 2020 · Preclinical models have shown encouraging anti-fibrotic results. Her … Jun 1, 2022 · The expression of HSP47 is proportional to the rate of collagen formation. . Thus, HSP47 is a potential drug target for fibrotic diseases. [11] HSP47 could be a Aug 25, 2023 · HSP47 expression is increased in cellular and animal models of pulmonary fibrosis and correlates with pathological manifestations in human interstitial lung diseases. Aug 25, 2023 · HSP47 expression is increased in cellular and animal models of pulmonary fibrosis and correlates with pathological manifestations in human interstitial lung diseases. Hsp47 dysregulation in these Feb 2, 2019 · HSP47 expresses strictly in parallel with collagen proteins by collagen-producing cells, and it has been demonstrated to be involved in various fibrotic disorders including liver, lung and skin fibrosis. May 1, 1999 · Furthermore, it has been demonstrated that HSP47 is induced in parallel with interstitial collagens during the development of hepatic fibrosis, supporting a direct role for this stress protein in the abnormal collagen deposit (31). The current review aims to provide light on how HSP70 and HSP47 affect hepatic fibrogenesis. We hypothesized that a C-terminal fragment of HSP47 (HSP47-C) could be quantified serologically and related to liver fibrosis stage. Fibrosis is the scarring of connective tissue, one attribute is the excess deposition of collagen in the extracellular matrix of tissue. Research has shown that HSPs have a role in fibrotic diseases. COL1A1 and HSPs. We evaluated the efficacy and safety of BMS-986263, a lipid nanoparticle delivering small interfering RNA designed to degrade HSP47 mRNA, for the treatment of advanced fibrosis. Recent studies have shown a close association between increased expression of HSP47 and excessive accumulation of collagens in scar tissues of various human and experimental fibrotic diseases. The increase in expression of HSP47 is associated with collagen-related diseases such as organ fibrosis in the liver, lungs, and gastrointestinal tract tumors. These results demonstrated that regeneration of chronically damaged liver indeed occurs after anti-fibrosis treatment even under continuous exposure to hepatotoxin, which promises a significant benefit of the anti-fibrosis therapy for refractory liver diseases. The identification of Compounds that interfere with the HSP47-collagen interaction is essential for the development of relevant therapeutics. Heat shock protein 47 (HSP47) is a collagen-specific molecular chaperone that is required for molecular maturation of various types of collagens. May 14, 2020 · These results demonstrated that the hepatic protective effects of Xiaochaihu decoction were mediated by HSP47/TGF-β axis. Aberrant HSP47 expression or malfunction has been associated with collagen-related disorders, most notably fibrosis. Mar 1, 2021 · Studies have found that HSP47 co-localizes with collagen in the area of pulmonary fibrosis, and HSP47 is mainly expressed in myofibroblasts. Therefore, HSP47 has attracted attention as a target of anti-fibrotic drugs for treatment of various organs, including the lungs [14]. Aug 19, 2021 · Heat shock protein 47 (HSP47), a collagen-specific molecular chaperone, is causally related to fibrotic diseases, including idiopathic pulmonary fibrosis. On the contrary, there are still many challenges in validating the effectiveness of a therapeutic drug targeting HSP47 for the treatment of pulmonary fibrosis. Anti-HSP47 strategies need to be further evaluated in clinical trials. [10] HSP47 has been shown to be pro-fibrosis in various fibrotic diseases. HSP47 may be a promising target for controlling pulmonary fibrosis because it regulates collagen synthesis and fibrogenesis. Dec 10, 2025 · In this study, the NDNB and HSP47 siRNA co-loaded nanomedicine (LNP-siHSP47/NDNB) was developed for enhancing liver fibrosis therapy by dual amplification effects on inhibiting collagen secretion for the first time. Aug 12, 2024 · Heat shock protein 47 (HSP47) is a chaperone protein responsible for regulating collagen maturation and transport, directly impacting collagen synthesis levels. The increase in circulating-HSP47 in lung fibrosis patients highlights the potential of HSP47 as a noninvasive biomarker and may represent an important step toward personalized medicine in fibrotic disorders. Heat shock protein 47 (HSP47), a key collagen chaperone, has been implicated in fibrosis development. Hsp47, a Col1 chaperone, was inhibited in liver fibrosis models by Hsp47 siRNA encapsulated in vitamin A-coupled liposomes, which are preferentially taken up by HSCs, showing anti-fibrotic effects [52]. Aug 25, 2023 · Among them, HSP47 has been reported to be implicated in fibrotic disorders such as scleroderma, renal interstitial fibrosis, peritoneal fibrosis, cardiac fibrosis, keloid fibrosis, and pulmonary fibrosis [13]. The specialty and necessity of HSP47 for collagen synthesis make it a good candidate for the treatment of fibrotic diseases. During the process of fibrosis, HSP47 is expressed and is involved in the production of collagen. Recent reports have uncovered new functions of HSP47 in various cellular processes. Additionally, our review looks into new therapeutic approaches that target HSP70 and HSP47 and could potentially be used as drug candidates to treat liver fibrosis, especially in cases of comorbidities. However, HSP47 siRNA induce myofibroblast apoptosis and prevent collagen accumulation, thus improving BLM-induced pulmonary fibrosis [123]. Various factors affect HSP47 expression directly or indirectly in pulmonary fibrosis models. Anti-HSP47 strategies need to be further evaluated in clinical trials. Heat shock protein 47 (HSP47) is a resident molecular chaperone of the endoplasmic reticulum (ER) that is essential for the proper folding of procollagen. shextfl pbyg tjmed fqqkqb pxfx zyj pozjtf zvmt dksdzj sud